The Inflammasome Therapeutics Summit is a leading global conference dedicated to advances in inflammasome research and drug development. Shaperon’s participation and keynote presentation underscore ...
The inflammasome, a multiprotein complex, plays a crucial role in the field of innate immunity. It is activated by pathogen-associated molecular patterns (PAMPs) or damage-associated molecular ...
Brenig has launched an early Phase 1 trial to evaluate BT-409, its experimental small molecule therapy, in healthy volunteers ...
The innate immune response is the body’s first line of defence, utilising specialised protein complexes known as inflammasomes to detect pathogenic insults and cellular damage. These multi‐protein ...
Advances in inflammasome biology are helping researchers address key selectivity and safety challenges in drug development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results